EWA
IMCR icon

EverSource Wealth Advisors’s Immunocore IMCR Stock Holding History

EverSource Wealth Advisors’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-183
Closed -$5.52K – 4475
2026
Q1 		$5.52K Buy
+183
New +$5.92K ﹤0.01% 3223
2025
Q2 		– Sell
-96
Closed -$2.85K – 4303
2025
Q1 		$2.85K Buy
+96
New +$2.88K ﹤0.01% 2754
2024
Q4 		– Sell
-167
Closed -$5.2K – 3782
2024
Q3 		$5.2K Hold
167
– – ﹤0.01% 2211
2024
Q2 		$6.63K Buy
+167
New +$8.52K ﹤0.01% 2088

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

EverSource Wealth Advisors's IMCR Position: Q2 2026 in Review

EverSource Wealth Advisors sold out of Immunocore (IMCR) in Q2 2026, closing a stake of 183 shares — an estimated $5.52K sold.

EverSource Wealth Advisors first reported a position in IMCR in Q2 2024 and held it in 4 quarters. The position peaked at $6.63K in Q2 2024. 135 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • EverSource Wealth Advisors reported no remaining Immunocore position as of Q2 2026 after selling out during the quarter.
  • EverSource Wealth Advisors sold 183 Immunocore shares in Q2 2026, an estimated $5.52K.
  • EverSource Wealth Advisors first reported a position in Immunocore in Q2 2024 and held it in 4 quarters.
  • EverSource Wealth Advisors's Immunocore position peaked at $6.63K in Q2 2024.
  • 135 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.